Hae-Ran Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hae-Ran Park has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Sung Kee Jo
Radiation Research Division for Bio-Technology, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI), Jeongeup, Republic of Korea.
6 shared publications - Ho Seong Seo
Research Division for Cyclotron Application, Korea Atomic Energy Research Institute, Jeongeup 56212, Republic of Korea
4 shared publications Hyun Jung Ji
4 shared publicationsMin-Kyu Kim
3 shared publicationsUhee Jung
Environmental Safety Research Team, Risk and Environmental Safety Research Division, Korea Atomic Energy Research Institute (KAERI), Daejeon, Republic of Korea
3 shared publications- Uhee Jung
Affiliations: Radiation Biotechnology Research Division, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea, Department of Radiation Biotechnology and Applied Radioisotope, University of Science and Technology (UST), Daejeon, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Skin‐Protective Effects of DeinoPol‐BRD125, a Microbial Exopolysaccharide From Deinococcus radiodurans , on Epidermal Hydration and Barrier Recovery
Deinococcus radiodurans is an extremophile bacterium renowned for its extraordinary resistance to environmental stress, partly mediated by its exopolysaccharide (EPS), DeinoPol. DeinoPol‐BRD125, derived from a high‐producing strain, exhibits potent antioxidative and cytoprotective properties, but its dermatological relevance remains largely unexplored. This study aimed to investigate the skin‐protective potential of DeinoPol‐BRD125 through integrated cellular and clinical evaluations. Human keratinocytes (HaCaT) were used to assess cytoprotection against UVB‐induced oxidative stress and modulation of hydration‐, barrier‐, and innate immunity–related genes via toll‐like receptor 2 (TLR2) activation. Two randomized, split‐site clinical studies were conducted to evaluate epidermal hydration, barrier recovery, and erythema after mechanical irritation following topical application of a 0.2% DeinoPol‐BRD125 formulation. DeinoPol‐BRD125 significantly attenuated UVB‐induced reactive oxygen species accumulation and improved keratinocyte survival. It markedly upregulated genes associated with hydration ( AQP3, HAS3 ), barrier integrity ( Loricrin, CerS3 ), and innate immunity ( DEFB1, DEFB2 ) and was associated with selective activation of TLR2 signaling. Clinically, topical DeinoPol‐BRD125 significantly enhanced skin hydration over 4 weeks compared with placebo and markedly accelerated transepidermal water loss recovery and erythema resolution following mechanical irritation. DeinoPol‐BRD125 is a biologically active microbial polysaccharide that enhances epidermal hydration, reinforces barrier function, and promotes recovery from skin irritation through coordinated antioxidant, immune, and structural mechanisms. These findings suggest that DeinoPol‐BRD125 is a promising bioactive ingredient for dermocosmetic applications aimed at improving cutaneous resilience and epidermal homeostasis.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessSkin‐Protective Effects of DeinoPol‐BRD125, a Microbial Exopolysaccharide From Deinococcus radiodurans , on Epidermal Hydration and Barrier Recovery
Deinococcus radiodurans is an extremophile bacterium renowned for its extraordinary resistance to environmental stress, partly mediated by its exopolysaccharide (EPS), DeinoPol. DeinoPol‐BRD125, derived from a high‐producing strain, exhibits potent antioxidative and cytoprotective properties, but its dermatological relevance remains largely unexplored. This study aimed to investigate the skin‐protective potential of DeinoPol‐BRD125 through integrated cellular and clinical evaluations. Human keratinocytes (HaCaT) were used to assess cytoprotection against UVB‐induced oxidative stress and modulation of hydration‐, barrier‐, and innate immunity–related genes via toll‐like receptor 2 (TLR2) activation. Two randomized, split‐site clinical studies were conducted to evaluate epidermal hydration, barrier recovery, and erythema after mechanical irritation following topical application of a 0.2% DeinoPol‐BRD125 formulation. DeinoPol‐BRD125 significantly attenuated UVB‐induced reactive oxygen species accumulation and improved keratinocyte survival. It markedly upregulated genes associated with hydration ( AQP3, HAS3 ), barrier integrity ( Loricrin, CerS3 ), and innate immunity ( DEFB1, DEFB2 ) and was associated with selective activation of TLR2 signaling. Clinically, topical DeinoPol‐BRD125 significantly enhanced skin hydration over 4 weeks compared with placebo and markedly accelerated transepidermal water loss recovery and erythema resolution following mechanical irritation. DeinoPol‐BRD125 is a biologically active microbial polysaccharide that enhances epidermal hydration, reinforces barrier function, and promotes recovery from skin irritation through coordinated antioxidant, immune, and structural mechanisms. These findings suggest that DeinoPol‐BRD125 is a promising bioactive ingredient for dermocosmetic applications aimed at improving cutaneous resilience and epidermal homeostasis.
- Open Access
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
A human lung organoid platform for studying radiation-induced pulmonary fibrosis and antifibrotic drug screening
Radiation-induced pulmonary injury and fibrosis (RIPI/RIPF) is a major complication following thoracic radiotherapy, characterized by persistent inflammation and excessive extracellular matrix deposition leading to irreversible lung disease. The development of antifibrotic drugs has been limited by the lack of physiologically relevant in vitro models that mimic the complex lung microenvironment. In this study, we established a human embryonic stem cells-derived human lung organoids (hLOs) model, comprising major epithelial cell types, including AT1, AT2, goblet, basal, club, and ciliated cells. Following repeated irradiation, hLOs exhibited key features of RIPF, including impaired proliferation, epithelial barrier disruption, epithelial-mesenchymal transition, upregulation of profibrotic cytokines, and extensive collagen deposition. Single-cell RNA sequencing revealed a marked reduction in proliferative AT2 cells and shifts in epithelial subpopulations, mimicking cellular dynamics observed in vivo. Importantly, Pirfenidone, an antifibrotic drug, significantly reduced the expression of TGF-β, α-SMA, and COL1A2 in irradiated hLOs. These findings demonstrate that our hESC-derived hLO model recapitulates key molecular and structural features of RIPF and offers a human-relevant, scalable platform for mechanistic studies and antifibrotic drug screening. This organoid system provides a time-efficient alternative to conventional animal models, enabling fibrosis-like responses, and may serve as a valuable tool for advancing therapeutic strategies against RIPI/RIPF.
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessA human lung organoid platform for studying radiation-induced pulmonary fibrosis and antifibrotic drug screening
Radiation-induced pulmonary injury and fibrosis (RIPI/RIPF) is a major complication following thoracic radiotherapy, characterized by persistent inflammation and excessive extracellular matrix deposition leading to irreversible lung disease. The development of antifibrotic drugs has been limited by the lack of physiologically relevant in vitro models that mimic the complex lung microenvironment. In this study, we established a human embryonic stem cells-derived human lung organoids (hLOs) model, comprising major epithelial cell types, including AT1, AT2, goblet, basal, club, and ciliated cells. Following repeated irradiation, hLOs exhibited key features of RIPF, including impaired proliferation, epithelial barrier disruption, epithelial-mesenchymal transition, upregulation of profibrotic cytokines, and extensive collagen deposition. Single-cell RNA sequencing revealed a marked reduction in proliferative AT2 cells and shifts in epithelial subpopulations, mimicking cellular dynamics observed in vivo. Importantly, Pirfenidone, an antifibrotic drug, significantly reduced the expression of TGF-β, α-SMA, and COL1A2 in irradiated hLOs. These findings demonstrate that our hESC-derived hLO model recapitulates key molecular and structural features of RIPF and offers a human-relevant, scalable platform for mechanistic studies and antifibrotic drug screening. This organoid system provides a time-efficient alternative to conventional animal models, enabling fibrosis-like responses, and may serve as a valuable tool for advancing therapeutic strategies against RIPI/RIPF.
- Open Access
- 26 October 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (11) , 2161
A Novel Deinococcus Antioxidant Peptide Mitigates Oxidative Stress in Irradiated CHO-K1 Cells
Reactive oxygen species (ROS), byproducts of cellular metabolism and environmental factors, are linked to diseases like cancer and aging. Antioxidant peptides (AOPs) have emerged as effective countermeasures against ROS-induced damage. The Deinococcus genus is well known for its extraordinary resilience to ionizing radiation (IR) and possesses complex antioxidant systems designed to neutralize ROS generated by IR. In this study, we developed four peptides, each containing 9 to 11 amino acids, from the leaderless mRNA (lmRNA) sequences of D. deserti. Lacking a 5′ untranslated region, lmRNAs directly initiate protein synthesis, potentially encoding small peptides such as AOPs. Of the four peptides, Ddes-P3 was found to exhibit significant antioxidant capabilities in vitro, effectively scavenging ABTS radicals. Ddes-P3 provided considerable defense against IR-induced oxidative stress in CHO-K1 cells, demonstrating a notable reduction in ROS production and lipid peroxidation. The peptide’s potential was highlighted by its ability to enhance cell survival and maintain mitochondrial membrane potential under irradiative stress, suggesting its utility as a nontoxic and effective radioprotector in mitigating radiation-induced cellular damage. This study explores the potential role of lmRNA in synthesizing AOPs within Deinococcus. Identifying lmRNAs that encode AOPs could deepen our understanding of their cellular resistance to oxidative stress and pave the way for creating innovative biotechnological and therapeutic AOPs.
- 26 October 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (11) , 2161
Open AccessA Novel Deinococcus Antioxidant Peptide Mitigates Oxidative Stress in Irradiated CHO-K1 Cells
Reactive oxygen species (ROS), byproducts of cellular metabolism and environmental factors, are linked to diseases like cancer and aging. Antioxidant peptides (AOPs) have emerged as effective countermeasures against ROS-induced damage. The Deinococcus genus is well known for its extraordinary resilience to ionizing radiation (IR) and possesses complex antioxidant systems designed to neutralize ROS generated by IR. In this study, we developed four peptides, each containing 9 to 11 amino acids, from the leaderless mRNA (lmRNA) sequences of D. deserti. Lacking a 5′ untranslated region, lmRNAs directly initiate protein synthesis, potentially encoding small peptides such as AOPs. Of the four peptides, Ddes-P3 was found to exhibit significant antioxidant capabilities in vitro, effectively scavenging ABTS radicals. Ddes-P3 provided considerable defense against IR-induced oxidative stress in CHO-K1 cells, demonstrating a notable reduction in ROS production and lipid peroxidation. The peptide’s potential was highlighted by its ability to enhance cell survival and maintain mitochondrial membrane potential under irradiative stress, suggesting its utility as a nontoxic and effective radioprotector in mitigating radiation-induced cellular damage. This study explores the potential role of lmRNA in synthesizing AOPs within Deinococcus. Identifying lmRNAs that encode AOPs could deepen our understanding of their cellular resistance to oxidative stress and pave the way for creating innovative biotechnological and therapeutic AOPs.
- Open Access
- 30 September 2024
- Published by The Korean Society for Microbiology and The Korean Society of Virology in Journal of Bacteriology and Virology
- Vol. 54 (3) , 213-224
Lung Organoids from Human Embryonic Stem Cells to Investigate Pneumococcal Serotype 23F that does not Infect Mouse
Streptococcus pneumoniae (S. pneumoniae, Pneumococcus) is a predominant pathogen in community-acquired pneumonia. Infection animal models using certain pneumococcal serotypes are well established, but some serotypes, such as ST14 and ST23F, exhibit low or negligible infectivity in mouse models, posing challenges for the development of comprehensive pneumococcal vaccines. In this study, we developed human lung organoids (hLOs) derived from human embryonic stem cells (hESCs) to model pneumococcal infection. hLOs were microinjected with serotype ST23F to assess its infective potential compared with ST4. Our results demonstrate that ST23F successfully colonizes and invades the epithelial cells of hLOs, triggering significant inflammatory responses. This response was quantitatively comparable to that induced by the highly virulent serotype ST4 in mouse models. This organoid-based infection model provides a viable and effective platform for studying pneumococcal serotypes that are inadequately represented in traditional mouse models. Furthermore, it underscores the potential utility of hLOs in the preclinical evaluation of novel multivalent pneumococcal conjugate vaccines, addressing serotypes with historically low virulence in animal models.
- 30 September 2024
- Published by The Korean Society for Microbiology and The Korean Society of Virology in Journal of Bacteriology and Virology
- Vol. 54 (3) , 213-224
Open AccessLung Organoids from Human Embryonic Stem Cells to Investigate Pneumococcal Serotype 23F that does not Infect Mouse
Streptococcus pneumoniae (S. pneumoniae, Pneumococcus) is a predominant pathogen in community-acquired pneumonia. Infection animal models using certain pneumococcal serotypes are well established, but some serotypes, such as ST14 and ST23F, exhibit low or negligible infectivity in mouse models, posing challenges for the development of comprehensive pneumococcal vaccines. In this study, we developed human lung organoids (hLOs) derived from human embryonic stem cells (hESCs) to model pneumococcal infection. hLOs were microinjected with serotype ST23F to assess its infective potential compared with ST4. Our results demonstrate that ST23F successfully colonizes and invades the epithelial cells of hLOs, triggering significant inflammatory responses. This response was quantitatively comparable to that induced by the highly virulent serotype ST4 in mouse models. This organoid-based infection model provides a viable and effective platform for studying pneumococcal serotypes that are inadequately represented in traditional mouse models. Furthermore, it underscores the potential utility of hLOs in the preclinical evaluation of novel multivalent pneumococcal conjugate vaccines, addressing serotypes with historically low virulence in animal models.
- Open Access
- 26 September 2022
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 898185
Radioprotection of deinococcal exopolysaccharide BRD125 by regenerating hematopoietic stem cells
There is a substantial need for the development of biomaterials for protecting hematopoietic stem cells and enhancing hematopoiesis after radiation damage. Bacterial exopolysaccharide (EPS) has been shown to be very attractive to researchers as a radioprotectant owing to its high antioxidant, anti-cancer, and limited adverse effects. In the present study, we isolated EPS from a novel strain, Deinococcus radiodurans BRD125, which produces EPS in high abundance, and investigated its applicability as a radioprotective biomaterial. We found that EPS isolated from EPS-rich D. radiodurans BRD125 (DeinoPol-BRD125) had an excellent free-radical scavenging effect and reduced irradiation-induced apoptosis. In addition, bone-marrow and spleen-cell apoptosis in irradiated mice were significantly reduced by DeinoPol-BRD125 administration. DeinoPol-BRD125 enhanced the expression of hematopoiesis-related cytokines such as GM-CSF, G-GSF, M-CSF, and SCF, thereby enhancing hematopoietic stem cells protection and regeneration. Taken together, our findings are the first to report the immunological mechanism of a novel radioprotectant, DeinoPol-BRD125, which might constitute an ideal radioprotective and radiation mitigating agent as a supplement drug during radiotherapy.
- 26 September 2022
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 898185
Open AccessRadioprotection of deinococcal exopolysaccharide BRD125 by regenerating hematopoietic stem cells
There is a substantial need for the development of biomaterials for protecting hematopoietic stem cells and enhancing hematopoiesis after radiation damage. Bacterial exopolysaccharide (EPS) has been shown to be very attractive to researchers as a radioprotectant owing to its high antioxidant, anti-cancer, and limited adverse effects. In the present study, we isolated EPS from a novel strain, Deinococcus radiodurans BRD125, which produces EPS in high abundance, and investigated its applicability as a radioprotective biomaterial. We found that EPS isolated from EPS-rich D. radiodurans BRD125 (DeinoPol-BRD125) had an excellent free-radical scavenging effect and reduced irradiation-induced apoptosis. In addition, bone-marrow and spleen-cell apoptosis in irradiated mice were significantly reduced by DeinoPol-BRD125 administration. DeinoPol-BRD125 enhanced the expression of hematopoiesis-related cytokines such as GM-CSF, G-GSF, M-CSF, and SCF, thereby enhancing hematopoietic stem cells protection and regeneration. Taken together, our findings are the first to report the immunological mechanism of a novel radioprotectant, DeinoPol-BRD125, which might constitute an ideal radioprotective and radiation mitigating agent as a supplement drug during radiotherapy.
- Open Access
18:0 Lyso PC Derived by Bioactivity-Based Molecular Networking from Lentil Mutant Lines and Its Effects on High-Fat Diet-Induced Obese Mice
Lentil (Lens culinaris; Fabaceae), one of the major pulse crops in the world, is an important source of proteins, prebiotics, lipids, and essential minerals as well as functional components such as flavonoids, polyphenols, and phenolic acids. To improve crop nutritional and medicinal traits, hybridization and mutation are widely used in plant breeding research. In this study, mutant lentil populations were generated by γ-irradiation for the development of new cultivars by inducing genetic diversity. Molecular networking via Global Natural Product Social Molecular Networking web platform and dipeptidyl peptide-IV inhibitor screening assay were utilized as tools for structure-based discovery of active components in active mutant lines selected among the lentil population. The bioactivity-based molecular networking analysis resulted in the annotation of the molecular class of phosphatidylcholine (PC) from the most active mutant line. Among PCs, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (18:0 Lyso PC) was selected for further in vivo study of anti-obesity effect in a high-fat diet (HFD)-induced obese mouse model. The administration of 18:0 Lyso PC not only prevented body weight gain and decreased relative gonadal adipose tissue weight, but also attenuated the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and leptin in the sera of HFD-induced obese mice. Additionally, 18:0 Lyso PC treatment inhibited the increase of adipocyte area and crown-like structures in adipose tissue. Therefore, these results suggest that 18:0 Lyso PC is a potential compound to have protective effects against obesity, improving obese phenotype induced by HFD.
Open Access18:0 Lyso PC Derived by Bioactivity-Based Molecular Networking from Lentil Mutant Lines and Its Effects on High-Fat Diet-Induced Obese Mice
Lentil (Lens culinaris; Fabaceae), one of the major pulse crops in the world, is an important source of proteins, prebiotics, lipids, and essential minerals as well as functional components such as flavonoids, polyphenols, and phenolic acids. To improve crop nutritional and medicinal traits, hybridization and mutation are widely used in plant breeding research. In this study, mutant lentil populations were generated by γ-irradiation for the development of new cultivars by inducing genetic diversity. Molecular networking via Global Natural Product Social Molecular Networking web platform and dipeptidyl peptide-IV inhibitor screening assay were utilized as tools for structure-based discovery of active components in active mutant lines selected among the lentil population. The bioactivity-based molecular networking analysis resulted in the annotation of the molecular class of phosphatidylcholine (PC) from the most active mutant line. Among PCs, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (18:0 Lyso PC) was selected for further in vivo study of anti-obesity effect in a high-fat diet (HFD)-induced obese mouse model. The administration of 18:0 Lyso PC not only prevented body weight gain and decreased relative gonadal adipose tissue weight, but also attenuated the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and leptin in the sera of HFD-induced obese mice. Additionally, 18:0 Lyso PC treatment inhibited the increase of adipocyte area and crown-like structures in adipose tissue. Therefore, these results suggest that 18:0 Lyso PC is a potential compound to have protective effects against obesity, improving obese phenotype induced by HFD.
- 28 April 2021
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 35 (3) , 1507-1513
Depletion of NK Cells Resistant to Ionizing Radiation Increases Mutations in Mice After Whole-body Irradiation
Background: Ionizing radiation is a very powerful genetic mutagenic agent. Although immune cells are very sensitive to radiation, their sensitivity varies between different types of immune cell. We hypothesized that radiation-resistant immune cells survive after irradiation and then play a role in removing mutant cells. Materials and Methods: Splenic lymphocytes and mice were irradiated with γ-rays. Cell populations were analyzed using flow cytometry after dyeing with antibodies and expression of B-cell lymphoma 2 (BCL2) was measured by western blot analysis. To deplete natural killer (NK) cells, anti-asialo GM1 antiserum was used. Micronuclei in polychromatic erythrocytes were measured by May-Grunwald/Giemsa staining. H-2Kb loss variant in T-cells induced by irradiation of B6C3F1 mice were detected by flow cytometry. Results: When splenic lymphocytes were irradiated in vitro, B cells notably died, while NK cells did not. In vivo, on the third day after whole-body irradiation, the total number of lymphocytes in the spleen decreased rapidly, but the proportion of NK cells was approximately three times higher than that of the normal control group. In addition, it was confirmed that high expression of BCL2 in NK cells was maintained after irradiation, whereas that of B-cells was not. Removal of NK cells by injection with anti-asialo GM1 antiserum immediately after irradiation increased the micronuclei of polychromatic erythrocytes in the bone marrow and the variant fraction with H-2kb loss in the spleen. Conclusion: These results provide important evidence that radioresistant NK cells apparently survive by escaping apoptosis in the early stages after irradiation, and work to eliminate mutant cells resulting from γ-ray irradiation. Future studies are needed to reveal why NK cells are resistant to radiation and the in-depth mechanisms involved in the elimination of radiation-induced mutant cells.
- 28 April 2021
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 35 (3) , 1507-1513
Depletion of NK Cells Resistant to Ionizing Radiation Increases Mutations in Mice After Whole-body Irradiation
Background: Ionizing radiation is a very powerful genetic mutagenic agent. Although immune cells are very sensitive to radiation, their sensitivity varies between different types of immune cell. We hypothesized that radiation-resistant immune cells survive after irradiation and then play a role in removing mutant cells. Materials and Methods: Splenic lymphocytes and mice were irradiated with γ-rays. Cell populations were analyzed using flow cytometry after dyeing with antibodies and expression of B-cell lymphoma 2 (BCL2) was measured by western blot analysis. To deplete natural killer (NK) cells, anti-asialo GM1 antiserum was used. Micronuclei in polychromatic erythrocytes were measured by May-Grunwald/Giemsa staining. H-2Kb loss variant in T-cells induced by irradiation of B6C3F1 mice were detected by flow cytometry. Results: When splenic lymphocytes were irradiated in vitro, B cells notably died, while NK cells did not. In vivo, on the third day after whole-body irradiation, the total number of lymphocytes in the spleen decreased rapidly, but the proportion of NK cells was approximately three times higher than that of the normal control group. In addition, it was confirmed that high expression of BCL2 in NK cells was maintained after irradiation, whereas that of B-cells was not. Removal of NK cells by injection with anti-asialo GM1 antiserum immediately after irradiation increased the micronuclei of polychromatic erythrocytes in the bone marrow and the variant fraction with H-2kb loss in the spleen. Conclusion: These results provide important evidence that radioresistant NK cells apparently survive by escaping apoptosis in the early stages after irradiation, and work to eliminate mutant cells resulting from γ-ray irradiation. Future studies are needed to reveal why NK cells are resistant to radiation and the in-depth mechanisms involved in the elimination of radiation-induced mutant cells.
- Open Access
- 20 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8) , 4284
Repeated Irradiation with γ-Ray Induces Cancer Stemness through TGF-β-DLX2 Signaling in the A549 Human Lung Cancer Cell Line
Cancer stem cells (CSCs) play an important role in cancer recurrence and metastasis. It is suggested that the CSC properties in heterogeneous cancer cells can be induced by ionizing radiation (IR). This study investigated the role of DLX2 in the radioresistance and CSC properties induced by IR in NSCLC cancer cells. Here, A549 cells were exposed to fractionated irradiation at a cumulative dose of 52 Gy (4 Gy × 13 times) for a generation of radioresistant cells. After fractionated irradiation, surviving A549 cells exhibited resistance to IR and enhanced expression of various cancer stem cell markers. They also showed upregulation of mesenchymal molecular markers and downregulation of epithelial molecular markers, correlating with an increase in the migration and invasion. Fractionated irradiation triggered the secretion of TGF-β1 and DLX2 expression. Interestingly, the increased DLX2 following fractionated irradiation seemed to induce the expression of the gene for the EGFR-ligand betacellulin via Smad2/3 signaling. To contrast, DLX2 knockdown dramatically decreased the expression of CSC markers, migration, and proliferation. Moreover, A549 cells expressing DLX2 shRNA formed tumors with a significantly smaller volume compared to those expressing control shDNA in a mouse xenograft assay. These results suggest that DLX2 overexpression in surviving NSCLC cancer cells after fractionated IR exposure is involved in the cancer stemness, radioresistance, EMT, tumor survival, and tumorigenic capability.
- 20 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8) , 4284
Open AccessRepeated Irradiation with γ-Ray Induces Cancer Stemness through TGF-β-DLX2 Signaling in the A549 Human Lung Cancer Cell Line
Cancer stem cells (CSCs) play an important role in cancer recurrence and metastasis. It is suggested that the CSC properties in heterogeneous cancer cells can be induced by ionizing radiation (IR). This study investigated the role of DLX2 in the radioresistance and CSC properties induced by IR in NSCLC cancer cells. Here, A549 cells were exposed to fractionated irradiation at a cumulative dose of 52 Gy (4 Gy × 13 times) for a generation of radioresistant cells. After fractionated irradiation, surviving A549 cells exhibited resistance to IR and enhanced expression of various cancer stem cell markers. They also showed upregulation of mesenchymal molecular markers and downregulation of epithelial molecular markers, correlating with an increase in the migration and invasion. Fractionated irradiation triggered the secretion of TGF-β1 and DLX2 expression. Interestingly, the increased DLX2 following fractionated irradiation seemed to induce the expression of the gene for the EGFR-ligand betacellulin via Smad2/3 signaling. To contrast, DLX2 knockdown dramatically decreased the expression of CSC markers, migration, and proliferation. Moreover, A549 cells expressing DLX2 shRNA formed tumors with a significantly smaller volume compared to those expressing control shDNA in a mouse xenograft assay. These results suggest that DLX2 overexpression in surviving NSCLC cancer cells after fractionated IR exposure is involved in the cancer stemness, radioresistance, EMT, tumor survival, and tumorigenic capability.
- Open Access
- 30 December 2017
- Published by Korean Association for Radiation Protection in Journal of Radiation Protection and Research
- Vol. 42 (4) , 177-188
Thoracic Irradiation Recruit M2 Macrophage into the Lung, Leading to Pneumonitis and Pulmonary Fibrosis
- 30 December 2017
- Published by Korean Association for Radiation Protection in Journal of Radiation Protection and Research
- Vol. 42 (4) , 177-188
Open AccessThoracic Irradiation Recruit M2 Macrophage into the Lung, Leading to Pneumonitis and Pulmonary Fibrosis
- Open Access
- 19 February 2016
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 16 (1) , 67
Herbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4
HemoHIM, which is an herbal preparation of three edible herbs (Angelicam gigas Nakai, Cnidium offinale Makino, and Peaonia japonica Miyabe), is known to have various biological and immunological activities, but the modulatory effects of this preparation on dendritic cells (DCs)-mediated immune responses have not been examined previously. DCs are a unique group of white blood cells that initiate primary immune responses by capturing, processing, and presenting antigens to T cells. In the present study, we investigated the effect of HemoHIM on the functional and phenotypic maturation of murine bone marrow-derived dendritic cells (BMDCs) both in vitro and in vivo. The expression of co-stimulatory molecules (CD40, CD80, CD86, MHC I, and MHC II) and the production of cytokines (IL-1β, IL-6, IL-12p70, and TNF-α) were increased by HemoHIM in BMDCs. Furthermore, the antigen-uptake ability of BMDCs was decreased by HemoHIM, and the antigen-presenting ability of HemoHIM-treated mature BMDCs increased TLR4-dependent CD4+ and CD8+ T cell responses. Our findings demonstrated that HemoHIM induces TLR4-mediated BMDCs functional and phenotypic maturation through in vivo and in vitro. And our study showed the antigen-presenting ability that HemoHIM-treated mature BMDCs increase CD4+ and CD8+ T cell responses by in vitro. These results suggest that HemoHIM has the potential to mediate DC immune responses.
- 19 February 2016
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 16 (1) , 67
Open AccessHerbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4
HemoHIM, which is an herbal preparation of three edible herbs (Angelicam gigas Nakai, Cnidium offinale Makino, and Peaonia japonica Miyabe), is known to have various biological and immunological activities, but the modulatory effects of this preparation on dendritic cells (DCs)-mediated immune responses have not been examined previously. DCs are a unique group of white blood cells that initiate primary immune responses by capturing, processing, and presenting antigens to T cells. In the present study, we investigated the effect of HemoHIM on the functional and phenotypic maturation of murine bone marrow-derived dendritic cells (BMDCs) both in vitro and in vivo. The expression of co-stimulatory molecules (CD40, CD80, CD86, MHC I, and MHC II) and the production of cytokines (IL-1β, IL-6, IL-12p70, and TNF-α) were increased by HemoHIM in BMDCs. Furthermore, the antigen-uptake ability of BMDCs was decreased by HemoHIM, and the antigen-presenting ability of HemoHIM-treated mature BMDCs increased TLR4-dependent CD4+ and CD8+ T cell responses. Our findings demonstrated that HemoHIM induces TLR4-mediated BMDCs functional and phenotypic maturation through in vivo and in vitro. And our study showed the antigen-presenting ability that HemoHIM-treated mature BMDCs increase CD4+ and CD8+ T cell responses by in vitro. These results suggest that HemoHIM has the potential to mediate DC immune responses.